14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.51 $3.16 Thursday, 2nd May 2024 GLYC stock ended at $1.72. This is 6.17% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 5.95% from a day low at $1.68 to a day high of $1.78.
90 days $1.51 $3.38
52 weeks $1.11 $3.53

Historical GlycoMimetics prices

Date Open High Low Close Volume
Feb 26, 2021 $3.41 $3.47 $3.27 $3.32 720 725
Feb 25, 2021 $3.45 $3.52 $3.32 $3.42 1 042 784
Feb 24, 2021 $3.56 $3.57 $3.42 $3.48 985 395
Feb 23, 2021 $3.65 $3.70 $3.36 $3.50 1 346 286
Feb 22, 2021 $3.85 $3.89 $3.76 $3.79 819 612
Feb 19, 2021 $3.91 $4.05 $3.80 $3.85 1 179 366
Feb 18, 2021 $3.82 $4.01 $3.62 $3.90 1 543 503
Feb 17, 2021 $3.96 $4.02 $3.81 $3.83 883 434
Feb 16, 2021 $4.07 $4.10 $3.95 $4.03 782 040
Feb 12, 2021 $4.05 $4.10 $3.92 $4.03 718 263
Feb 11, 2021 $4.07 $4.16 $3.99 $4.07 774 542
Feb 10, 2021 $4.28 $4.40 $3.96 $4.06 1 205 239
Feb 09, 2021 $4.22 $4.37 $4.13 $4.22 1 141 861
Feb 08, 2021 $4.09 $4.40 $4.02 $4.20 1 415 103
Feb 05, 2021 $4.00 $4.08 $3.91 $4.08 530 340
Feb 04, 2021 $3.97 $4.04 $3.85 $4.02 623 681
Feb 03, 2021 $3.75 $3.98 $3.75 $3.95 939 993
Feb 02, 2021 $3.69 $3.77 $3.60 $3.75 496 203
Feb 01, 2021 $3.67 $3.69 $3.55 $3.64 429 719
Jan 29, 2021 $3.70 $3.80 $3.53 $3.63 762 899
Jan 28, 2021 $3.79 $3.85 $3.66 $3.66 915 221
Jan 27, 2021 $3.90 $4.00 $3.75 $3.79 842 406
Jan 26, 2021 $4.10 $4.25 $3.98 $4.03 1 096 333
Jan 25, 2021 $3.90 $4.12 $3.81 $4.10 1 067 081
Jan 22, 2021 $3.81 $3.90 $3.76 $3.89 490 078
Click to get the best stock tips daily for free!

About GlycoMimetics

GlycoMimetics GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML), as well as in phase 3 trial to treat relapsed/refractory AML. In addition, the company is developing G... GLYC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT